Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product.
Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.
No reviews to display
17 Jun 2014
Almac Supports Clients in Response to New, Stringent, FDA Heavy Metal Mandates by Investing in ICP-MS Equipment
03 Jun 2014
25 Feb 2014
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
27 Nov 2013
11 Nov 2013